← FDA Drug Approvals (Drugs@FDA)
TADALAFIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2019-02-05
Drug application
- FDA Application #
ANDA210392- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TADALAFIL
- Generic name
- TADALAFIL
- Active ingredients
- TADALAFIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AJANTA PHARMA LTD
- Manufacturer
- Quallent Pharmaceuticals Health LLC
- First approval
- 2019-02-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown